3-62372376-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_018008.4(FEZF2):c.493G>A(p.Ala165Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000391 in 1,611,182 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018008.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FEZF2 | NM_018008.4 | c.493G>A | p.Ala165Thr | missense_variant | 2/5 | ENST00000283268.8 | NP_060478.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FEZF2 | ENST00000283268.8 | c.493G>A | p.Ala165Thr | missense_variant | 2/5 | 1 | NM_018008.4 | ENSP00000283268.3 | ||
FEZF2 | ENST00000475839.1 | c.493G>A | p.Ala165Thr | missense_variant | 1/4 | 1 | ENSP00000418804.1 | |||
FEZF2 | ENST00000486811.5 | c.493G>A | p.Ala165Thr | missense_variant | 3/6 | 5 | ENSP00000418589.1 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152174Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000577 AC: 14AN: 242602Hom.: 0 AF XY: 0.0000602 AC XY: 8AN XY: 132880
GnomAD4 exome AF: 0.0000274 AC: 40AN: 1459008Hom.: 0 Cov.: 32 AF XY: 0.0000262 AC XY: 19AN XY: 725968
GnomAD4 genome AF: 0.000151 AC: 23AN: 152174Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74328
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 22, 2023 | The c.493G>A (p.A165T) alteration is located in exon 2 (coding exon 1) of the FEZF2 gene. This alteration results from a G to A substitution at nucleotide position 493, causing the alanine (A) at amino acid position 165 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at